Under construction – not a live service
Sign in

NCT05685095Withdrawn

Programmes de Marche Active et qualité de Vie Dans la Maladie de Parkinson

Impact de Programmes de Marche Active Sur la Marche en Situation de Vie Quotidienne et la qualité de Vie Dans la Maladie de Parkinson

Source: ClinicalTrials.gov · Last updated 6 Apr 2023

Reason given: personnel involved in clinical trial will not be available to conduct the research

Brief summary (registry, in English)

The aim of this randomized controlled pilot trial is to assess the impact of different gait rehabilitation programs on the level of physical activity and gait in daily life in patients with Parkinson's disease (PD). Two groups of 25 patients with PD will benefit from one of two gait training programs (treadmill vs. nordic walking), 3 times a week for 12 weeks. Activity level and number of steps will be remotely recorded over 7 days before, at the end, 3 and 6 months after the end of the program. Quality of life will be recorded at each time point. The impact of the gait programs on the patients' level of daily activity will be examined, comparing the changes brought about by the two programs, taking into account the modulating influence of age and cognitive function. Gait under conditions of daily life will be compared to gait parameters collected in the laboratory.

Status (registry)
Withdrawn
Study type
Interventional
Enrollment
0 (actual)
First submitted
1 Sept 2022
Start date
Feb 2023
Primary completion date
Feb 2025
Lead sponsor
University Hospital, Grenoble
NCT number
NCT05685095

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Atypical parkinsonian syndrome
  • Any condition (other than PD) interfering with gait

Other

  • Cardiovascular pathology preventing moderate physical exercise
  • Orthostatic hypotension
  • pregnant or nursing

Who the study is looking for

  • Parkinson's disease, diagnosed for at least 2 years,
  • Medical treatment (if any) unchanged in the past 4 weeks at least
  • Hoehn \& Yahr score < 3
  • Montreal cognitive assessment (MOCA) score between 20 and 30
  • Able to understand the aim and methods of the study and provide signed informed consent-

Age in the registry: 30 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
CHU Grenoble AlpesGrenobleFranceUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.